A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

NCT04804059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Fungal Infection

Interventions

DRUG: [14C]-APX001 Oral Solution
DRUG: [14C]-APX001 Solution for Infusion

Sponsor

Basilea Pharmaceutica